25.46
Schlusskurs vom Vortag:
$25.32
Offen:
$24.77
24-Stunden-Volumen:
8,727
Relative Volume:
0.03
Marktkapitalisierung:
$422.20M
Einnahmen:
$5.93B
Nettoeinkommen (Verlust:
$-405.35M
KGV:
-1.0458
EPS:
-24.3461
Netto-Cashflow:
$-148.87M
1W Leistung:
+2.29%
1M Leistung:
+152.80%
6M Leistung:
+9.64%
1J Leistung:
-73.92%
Agilon Health Inc Stock (AGL) Company Profile
Firmenname
Agilon Health Inc
Sektor
Branche
Telefon
562-256-3800
Adresse
440 POLARIS PARKWAY, WESTERVILLE
Compare AGL vs HCA, THC, FMS, ENSG, UHS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
AGL
Agilon Health Inc
|
25.34 | 421.83M | 5.93B | -405.35M | -148.87M | -24.35 |
|
HCA
Hca Healthcare Inc
|
444.68 | 99.18B | 76.39B | 7.81B | 7.93B | 29.08 |
|
THC
Tenet Healthcare Corp
|
186.37 | 16.25B | 21.31B | 2.37B | 2.53B | 15.49 |
|
FMS
Fresenius Medical Care Ag Adr
|
22.67 | 12.36B | 22.18B | 1.36B | 2.00B | 1.9216 |
|
ENSG
Ensign Group Inc
|
192.49 | 11.10B | 5.06B | 344.26M | 370.71M | 5.8446 |
|
UHS
Universal Health Services Inc
|
175.53 | 10.96B | 17.36B | 1.51B | 849.25M | 23.15 |
Agilon Health Inc Stock (AGL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-20 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2025-08-06 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-04-25 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-04-08 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2025-01-10 | Hochstufung | Citigroup | Sell → Neutral |
| 2025-01-10 | Eingeleitet | Needham | Hold |
| 2024-12-16 | Eingeleitet | Macquarie | Neutral |
| 2024-12-11 | Eingeleitet | Bernstein | Mkt Perform |
| 2024-11-11 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-11-08 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-10-30 | Herabstufung | Citigroup | Neutral → Sell |
| 2024-10-02 | Herabstufung | BofA Securities | Buy → Underperform |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Neutral |
| 2024-04-22 | Eingeleitet | Citigroup | Neutral |
| 2024-03-06 | Eingeleitet | Barclays | Underweight |
| 2024-02-26 | Herabstufung | Jefferies | Buy → Hold |
| 2024-02-26 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2024-01-08 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-01-08 | Herabstufung | Stifel | Buy → Hold |
| 2024-01-08 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-01-05 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-01-05 | Herabstufung | Truist | Buy → Hold |
| 2023-12-11 | Herabstufung | Goldman | Buy → Neutral |
| 2023-12-06 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-11-21 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-10-20 | Eingeleitet | The Benchmark Company | Buy |
| 2023-06-13 | Eingeleitet | Evercore ISI | In-line |
| 2022-12-09 | Eingeleitet | Stifel | Buy |
| 2022-09-14 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-09-12 | Eingeleitet | Goldman | Buy |
| 2022-09-07 | Fortgesetzt | Truist | Buy |
| 2022-06-24 | Eingeleitet | BTIG Research | Neutral |
| 2022-03-30 | Eingeleitet | Guggenheim | Buy |
| 2021-10-20 | Eingeleitet | Jefferies | Buy |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-05-11 | Eingeleitet | William Blair | Outperform |
| 2021-05-10 | Eingeleitet | BofA Securities | Buy |
| 2021-05-10 | Eingeleitet | Deutsche Bank | Buy |
| 2021-05-10 | Eingeleitet | Goldman | Buy |
| 2021-05-10 | Eingeleitet | JP Morgan | Overweight |
| 2021-05-10 | Eingeleitet | Truist | Buy |
| 2021-05-10 | Eingeleitet | Wells Fargo | Overweight |
| 2021-05-10 | Eingeleitet | Wolfe Research | Outperform |
Alle ansehen
Agilon Health Inc Aktie (AGL) Neueste Nachrichten
agilon health names Tim O’Rourke as new CEO effective May 7 - Investing.com Canada
Healthcare management services company agilon health, inc. officially announces major executive leadership changes - Bitget
Tim O’Rourke to lead agilon health (NYSE: AGL) as new CEO - Stock Titan
agilon health Appoints Tim O’Rourke as Chief Executive Officer - Business Wire
agilon health CEO steps down; interim lead appointed - MSN
Agilon Health shares plunge after Q2 miss, leadership shakeup, and suspended guidance - MSN
Agilon Health announces 1-for-25 reverse stock split - MSN
Agilon Health | DEFA14A: Others - Moomoo
Agilon Health | ARS: Annual Report to Security Holders - Moomoo
Agilon PE Backers Get Insider Trading Claims Cut From Lawsuit - Bloomberg Law News
[ARS] agilon health, inc. SEC Filing - Stock Titan
Why Are agilon health (AGL) Shares Soaring Today - Yahoo Finance
Agilon (AGL) Cash Flow Analysis | Q4 2025: Below ExpectationsCrowd Sentiment Stocks - Xã Châu Thành
agilon health (NYSE: AGL) sets 2026 virtual meeting and outlines 2025 losses - Stock Titan
Is Agilon Health (AGL) Outperforming Other Medical Stocks This Year? - qz.com
agilon health inc Stock (AGL) Moved Down by 9.82% on Apr 20: Drivers Behind the Movement - TradingKey
agilon health's Vitals Are Improving (Upgrade) (NYSE:AGL) - Seeking Alpha
Is Agilon (AGL) stock a high-risk investment now (+3.37%) 2026-04-20Expert Stock Picks - Cổng thông tin điện tử Tỉnh Sơn La
AGL Stock Price, Quote & Chart | AGILON HEALTH INC (NYSE:AGL) - ChartMill
agilon health inc stock (US00857U1079): Why Google Discover changes matter more now for healthcare i - AD HOC NEWS
Why Agilon Health (AGL) is doing a 1-for-25 reverse split to stay NYSE-compliant - MSN
AGL|agilon health inc|Price:28.300|Chg%:-1.75 - TradingKey
agilon health (AGL) CTO has 426 shares withheld to cover RSU taxes - Stock Titan
Agilon Health (AGL) CMO has 675 shares withheld to cover RSU taxes - Stock Titan
3 Reasons AGL is Risky and 1 Stock to Buy Instead - Yahoo Finance
Agilon Health (NYSE:AGL) Stock Price Up 11.6%Should You Buy? - MarketBeat
agilon health (NYSE: AGL) CAO reports RSU tax-withholding share transactions - Stock Titan
Outpatient & Specialty Care Stocks Q4 Recap: Benchmarking agilon health (NYSE:AGL) - Yahoo Finance
agilon health inc stock (US00857U1079): Why its total cost of care model matters more now for invest - AD HOC NEWS
Agilon Health, Inc. (NYSE:AGL) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Agilon Health (AGL) price target increased by 2,183.69% to 21.99 - MSN
The Gross Law Firm Notifies agilon health, inc. Investors of a C - GuruFocus
Big Picture: What is the Moat Score of agilon health incWeekly Profit Analysis & Community Verified Trade Signals - baoquankhu1.vn
agilon health (AGL) Price Target Decreased by 25.00% to 1.07 - MSN
Bernstein maintains agilon health stock rating, cites 2026 outlook By Investing.com - Investing.com India
Bernstein maintains agilon health stock rating, cites 2026 outlook - Investing.com
Did agilon health, inc. Insiders Breach their Fiduciary Duties t - GuruFocus
Did agilon health, inc. Insiders Breach their Fiduciary Duties to Shareholders? - ChartMill
AGL Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Value Recap: Is agilon health inc currently under institutional pressure2026 Levels & Long-Term Growth Plans - baoquankhu1.vn
Published on: 2026-04-08 05:19:06 - baoquankhu1.vn
Astrana Health, Evolent Health, Neogen, agilon health, and Fortrea Shares Are Soaring, What You Need To Know - Yahoo Finance
Key facts: Agilon Health up 13.6% after Medicare rate hike; Q1 May 6 - TradingView — Track All Markets
agilon health Sets Date to Report Q1 2026 Earnings - National Today
agilon health Sets Date to Report First Quarter 2026 Financial Results - National Today
Agilon Health (AGL) Soars 25% in Intraday Surge: What’s Driving This Volatile Rally? - Bitget
Finanzdaten der Agilon Health Inc-Aktie (AGL)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):